PF-07832837 is under clinical development by Pfizer and currently in Phase I for Asthma. According to GlobalData, Phase I drugs for Asthma have a 74% phase transition success rate (PTSR) indication ...

Bempikibart (ADX-914) is under development for the treatment of atopic dermatitis and alopecia areata. It is administered through subcutaneous route and acts by targeting interleukin-7 receptor (IL-7R ...

VANCOUVER, British Columbia, Dec. 31, 2024 (GLOBE NEWSWIRE) -- VERSES AI Inc. (CBOE:VERS) (OTCQB:VRSSF) ("VERSES'' or the ...

Bloomberg Green looks at how energy markets, consumer spending and diplomacy will shape the future of the planet this year.

VERSES AI Inc. (CBOE:VERS) (OTCQB:VRSSF) ("VERSES' or the "Company"), a cognitive computing company specializing in next generation intelligent ...

The cryptocurrency space is always in the headlines, and almost always for good reasons like a heavy rate of return. Elon ...

Moderna/Merck partnership and its potential in personalised cancer therapies are good opportunities for long-term investors.

The war between Russia and Ukraine has now entered its 1044th day since starting on February 24, 2022. In this relatively short time, drones have become a bona fide tour de force on the battlefield.

AVITA Medical's Q3 report showed strong sequential sales growth and a lower burn rate. My confidence in it reaching breakeven ...

As 2024 ends, India’s AI sector has transitioned from its experimentation stage to strategic adoption, primarily driven by ...

Signals from the incoming administration indicate a possible focus on policy pivots that they believe will result in a more ...

With hydrocarbon demand showing few signs of peaking and shareholder activism waning, oil companies will likely invest more in the upstream and LNG.